Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy

Clinical trial NCT00418431 · WITHDRAWN

Trial details

NCT number: NCT00418431
Sponsor: Asociación para Evitar la Ceguera en México
Status: WITHDRAWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Central Serous Chorioretinopathy

Start date: 2006-04-01
Primary completion: 2006-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.